Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection

Virology

Volumn 422, Issue 1, 2012, Pages 6-12

  McElroy, Anita K ^a,b   Nichol, Stuart T ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Hemorrhagic fever; Immunity; Interferon; Macrophage; Monocyte; Rift Valley fever virus; RVFV; Survival; Tumor necrosis factor

Indexed keywords

ALPHA2 INTERFERON; BETA INTERFERON; CYTOKINE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MICROBIOLOGICAL PARAMETERS; MONOCYTE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; VIRUS INHIBITION; VIRUS RECOMBINANT; WILD TYPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; FEMALE; HUMANS; IMMUNITY, INNATE; INTERFERON-ALPHA; INTERFERON-BETA; MACROPHAGES; MALE; MIDDLE AGED; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; RNA, VIRAL; TUMOR NECROSIS FACTOR-ALPHA; VIRAL NONSTRUCTURAL PROTEINS;

ANIMALIA; RIFT VALLEY FEVER VIRUS;

EID: 82355191675     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.09.023     Document Type: Article

References (56)

1. Anderson G.W., Slone T.W., Peters C.J. Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats. Microb. Pathog. 1987, 2:283-293.
2. Anderson G.W., Lee J.O., Anderson A.O., Powell N., Mangiafico J.A., Meadors G. Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats. Vaccine 1991, 9:710-714.
3. Baize S., Kaplon J., Faure C., Pannetier D., Georges-Courbot M.C., Deubel V. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 2004, 172:2861-2869.
4. Baize S., Pannetier D., Faure C., Marianneau P., Marendat I., Georges-Courbot M.C., Deubel V. Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. Microbes Infect. 2006, 8:1194-1202.
5. Baize S., Marianneau P., Loth P., Reynard S., Journeaux A., Chevallier M., Tordo N., Deubel V., Contamin H. Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J. Virol. 2009, 83:5890-5903.
6. Billecocq A., Spiegel M., Vialat P., Kohl A., Weber F., Bouloy M., Haller O. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 2004, 78:9798-9806.
7. Bird B.H., Bawiec D.A., Ksiazek T.G., Shoemaker T.R., Nichol S.T. Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus. J. Clin. Microbiol. 2007, 45:3506-3513.
8. Bird B.H., Khristova M.L., Rollin P.E., Ksiazek T.G., Nichol S.T. Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J. Virol. 2007, 81:2805-2816.
9. Bird B.H., Albarino C.G., Hartman A.L., Erickson B.R., Ksiazek T.G., Nichol S.T. Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J. Virol. 2008, 82:2681-2691.
10. Bird B.H., Ksiazek T.G., Nichol S.T., Maclachlan N.J. Rift Valley fever virus. J. Am. Vet. Med. Assoc. 2009, 234:883-893.
11. Bouloy M., Janzen C., Vialat P., Khun H., Pavlovic J., Huerre M., Haller O. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J. Virol. 2001, 75:1371-1377.
12. Cecil R.L., Goldman L., Ausiello D.A. Cecil medicine 2008, Saunders Elsevier, Philadelphia. 23rd ed.
13. Centers for Disease Control and P. Rift Valley fever outbreak-Kenya, November 2006-January 2007. MMWR-Morbidity & Mortality Weekly Report 2007, 56:73-76.
14. Connolly-Andersen A.M., Douagi I., Kraus A.A., Mirazimi A. Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 2009, 390:157-162.
15. Daubney R., Hudson J.R., Garnham P.C. Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa. J. Pathol. Bacteriol. 1931, 34:545-579.
16. Desmyter J., Melnick J.L., Rawls W.E. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J. Virol. 1968, 2:955-961.
17. do Valle T.Z., Billecocq A., Guillemot L., Alberts R., Gommet C., Geffers R., Calabrese K., Schughart K., Bouloy M., Montagutelli X., Panthier J.J. A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever. J. Immunol. 2010, 185:6146-6156.
18. Dungu B., Louw I., Lubisi A., Hunter P., von Teichman B.F., Bouloy M. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep. Vaccine 2010, 28:4581-4587.
19. Emeny J.M., Morgan M.J. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 1979, 43:247-252.
20. Ergonul O., Tuncbilek S., Baykam N., Celikbas A., Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 2006, 193:941-944.
21. Fields B.N., Knipe D.M., Howley P.M. Fields' virology 2007, Wolters kluwer/Lippincott Williams & Wilkins, Philadelphia. 5th ed.
22. Gerrard S.R., Bird B.H., Albarino C.G., Nichol S.T. The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virology 2007, 359:459-465.
23. Gras G., Kaul M. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 2010, 7:30.
24. Gupta M., Mahanty S., Ahmed R., Rollin P.E. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology 2001, 284:20-25.
25. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., Wagner V., Pichlmair A., Schneider U., Muhlberger E., Mirazimi A., Weber F. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 2008, 3:e2032.
26. Habjan M., Penski N., Spiegel M., Weber F. T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J. Gen. Virol. 2008, 89:2157-2166.
27. Habjan M., Pichlmair A., Elliott R.M., Overby A.K., Glatter T., Gstaiger M., Superti-Furga G., Unger H., Weber F. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J. Virol. 2009, 83:4365-4375.
28. Hilkens C.M., Schlaak J.F., Kerr I.M. Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J. Immunol. 2003, 171:5255-5263.
29. Hiscott J., Ryals J., Dierks P., Hofmann V., Weissmann C. The expression of human interferon alpha genes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1984, 307:217-226.
30. Hutchinson K.L., Rollin P.E. Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J. Infect. Dis. 2007, 196(Suppl. 2):S357-S363.
31. Ikegami T., Won S., Peters C.J., Makino S. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J. Virol. 2006, 80:2933-2940.
32. Ikegami T., Narayanan K., Won S., Kamitani W., Peters C.J., Makino S. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog. 2009, 5:e1000287.
33. Kamal S.A. Pathological studies on postvaccinal reactions of Rift Valley fever in goats. Virol. J. 2009, 6:94.
34. Koenig S., Gendelman H.E., Orenstein J.M., Dal Canto M.C., Pezeshkpour G.H., Yungbluth M., Janotta F., Aksamit A., Martin M.A., Fauci A.S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986, 233:1089-1093.
35. Le May N., Dubaele S., Proietti De Santis L., Billecocq A., Bouloy M., Egly J.M. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 2004, 116:541-550.
36. Le May N., Mansuroglu Z., Leger P., Josse T., Blot G., Billecocq A., Flick R., Jacob Y., Bonnefoy E., Bouloy M. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog. 2008, 4:e13.
37. Lukashevich I.S., Maryankova R., Vladyko A.S., Nashkevich N., Koleda S., Djavani M., Horejsh D., Voitenok N.N., Salvato M.S. Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J. Med. Virol. 1999, 59:552-560.
38. Madani T.A., Al-Mazrou Y.Y., Al-Jeffri M.H., Mishkhas A.A., Al-Rabeah A.M., Turkistani A.M., Al-Sayed M.O., Abodahish A.A., Khan A.S., Ksiazek T.G., Shobokshi O. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin. Infect. Dis. 2003, 37:1084-1092. [See comment].
39. Mahanty S., Bausch D.G., Thomas R.L., Goba A., Bah A., Peters C.J., Rollin P.E. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J. Infect. Dis. 2001, 183:1713-1721.
40. Mansuroglu Z., Josse T., Gilleron J., Billecocq A., Leger P., Bouloy M., Bonnefoy E. Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. J. Virol. 2010, 84:928-939.
41. Medeot S.I., Contigiani M.S., Sabattini M.S., Camara A. The role of mononuclear blood cells in experimental Junin virus spread to the central nervous system. Viral Immunol. 1995, 8:101-108.
42. Miagostovich M.P., Ramos R.G., Nicol A.F., Nogueira R.M., Cuzzi-Maya T., Oliveira A.V., Marchevsky R.S., Mesquita R.P., Schatzmayr H.G. Retrospective study on dengue fatal cases. Clin. Neuropathol. 1997, 16:204-208.
43. Muller R., Saluzzo J.F., Lopez N., Dreier T., Turell M., Smith J., Bouloy M. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am. J. Trop. Med. Hyg. 1995, 53:405-411.
44. Papa A., Bino S., Velo E., Harxhi A., Kota M., Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 2006, 36:272-276.
45. Paul W.E. Fundamental immunology 2008, Wolters Kluwer / Lippincott Williams & Wilkins, Philadelphia. 6th ed.
46. Peters C.J., Slone T.W. Inbred rat strains mimic the disparate human response to Rift Valley fever virus infection. J. Med. Virol. 1982, 10:45-54.
47. Ritter M., Bouloy M., Vialat P., Janzen C., Haller O., Frese M. Resistance to Rift Valley fever virus in Rattus norvegicus: genetic variability within certain 'inbred' strains. J. Gen. Virol. 2000, 81:2683-2688.
48. Shieh W.J., Paddock C.D., Lederman E., Rao C.Y., Gould L.H., Mohamed M., Mosha F., Mghamba J., Bloland P., Njenga M.K., Mutonga D., Samuel A.A., Guarner J., Breiman R.F., Zaki S.R. Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007. Am. J. Trop. Med. Hyg. 2010, 83:38-42.
49. Smith D.R., Steele K.E., Shamblin J., Honko A., Johnson J., Reed C., Kennedy M., Chapman J.L., Hensley L.E. The pathogenesis of Rift Valley fever virus in the mouse model. Virology 2010, 407:256-267.
50. Stroher U., West E., Bugany H., Klenk H.D., Schnittler H.J., Feldmann H. Infection and activation of monocytes by Marburg and Ebola viruses. J. Virol. 2001, 75:11025-11033.
51. Swanepoel R., Coetzer J.A.W. Rift Valley fever. Infectious Diseases of Livestock with Special References to South Africa 1994, 688-717. Oxford University Press, Capetown. T.G. Coetzer JAW, R.C. Tutsin (Eds.).
52. Turell M.J., Wilson W.C., Bennett K.E. Potential for North American mosquitoes (Diptera: Culicidae) to transmit rift valley fever virus. J. Med. Entomol. 2010, 47:884-889.
53. Vialat P., Billecocq A., Kohl A., Bouloy M. The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice. J. Virol. 2000, 74:1538-1543.
54. Villinger F., Rollin P.E., Brar S.S., Chikkala N.F., Winter J., Sundstrom J.B., Zaki S.R., Swanepoel R., Ansari A.A., Peters C.J. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 1999, 179(Suppl. 1):S188-S191.
55. Wilkinson J., Radkowski M., Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. J. Virol. 2009, 83:1312-1319.
56. Yadani F.Z., Kohl A., Prehaud C., Billecocq A., Bouloy M. The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. J. Virol. 1999, 73:5018-5025.